StockNews.AI
TWST
StockNews.AI
209 days

Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025

1. Twist Bioscience will release Q1 fiscal results on February 3, 2025. 2. A conference call will follow to discuss results and business updates. 3. Twist's unique DNA synthesis technology supports diverse applications across multiple sectors. 4. The company is expanding into digital data storage and biologics drug discovery.

Earnings
+7.79%Current Return
VS
+0.82%S&P 500
$50.4501/22 08:48 AM EDTEvent Start
$54.3801/23 03:18 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Neutral?

The upcoming earnings report may clarify revenue trends, much like past quarters impacted TWST.

How important is it?

Earnings reports typically influence stock prices significantly, especially in biotech sectors.

Why Short Term?

Immediate focus on Q1 results with short-lived market reactions possible.

Related Companies

TWST
SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it will issue its financial results for the fiscal 2025 first quarter ended December 31, 2024, before the opening of the market on February 3, 2025. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be accessible from the company’s website prior to the conference call through the Investor Relations section under the “Company” tab at www.twistbioscience.com. The conference call will be webcast live through the Investor Relations section under the “Company” tab at www.twistbioscience.com. Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clicking here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks. About Twist Bioscience Corporation Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research. Follow us on LinkedIn | X | YouTube | Instagram | Bluesky

Related News